Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide

To overcome safety limitations of tenofovir-disoproxil, EASL guidelines proposed switching chronic hepatitis B patients older than 60 years or with bone or renal disease to tenofovir-alafenamide or entecavir.

Source: Digestive and Liver Disease - July 19, 2020 Category: Gastroenterology Authors: Luisa Roade, Alessandro Loglio, Marta Borghi, Mar Riveiro-Barciela, Roberta Soffredini, Floriana Facchetti, Dhanai di Paolo, David Tabernero, Giovanna Lunghi, Rafael Esteban, Maria Buti, Pietro Lampertico Tags: Original Article Source Type: research